Published in

Oxford University Press (OUP), FEMS Immunology and Medical Microbiology, 2(41), p. 93-100, 2004

DOI: 10.1016/j.femsim.2004.01.004

Links

Tools

Export citation

Search in Google Scholar

Antibody bound to the surface antigen MPB83 ofMycobacterium bovisenhances survival against high dose and low dose challenge

Journal article published in 2004 by Mark A. Chambers ORCID, Dolores Gavier-Widã©n, R. Glyn Hewinson
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Tuberculosis caused by infection with Mycobacterium tuberculosis or Mycobacterium bovis is a significant disease of man and animals. Whilst cellular immunity is the major immunological component required for protection against these organisms, recent reports have suggested that monoclonal antibodies can modify infection with M. tuberculosis. To test whether the same was true for M. bovis infection, we determined the effect of preincubation of M. bovis with a monoclonal antibody on subsequent intravenous infection of mice. Antibodies bound to the surface of M. bovis increased the survival time of mice infected with M. bovis and changed the morphology of granulomas and the distribution of acid-fast bacilli in the lung. These studies suggest that antibodies directed to the surface of virulent mycobacteria can modulate their virulence in vivo.